After Natco, Bajaj Healthcare files compulsory license against Eli Lilly; EPO Enlarged Board of Appeal issues decision on ‘double patenting’ and more

In this week’s patent news: After Natco, Bajaj Healthcare files compulsory license application against Eli Lilly for Baricitinib; EPO Enlarged Board of Appeal issues Decision...

Read more about After Natco, Bajaj Healthcare files compulsory license against Eli Lilly; EPO Enlarged Board of Appeal issues decision on ‘double patenting’ and more

IPO notifies Supreme Court’s latest decision on ‘Extension of Limitation’; Monsanto and Nuziveedu settle long standing patent dispute and more

IPO notifies Supreme Court’s latest decision on ‘Extension of Limitation’; Monsanto and Nuziveedu settle long standing patent dispute; EPO to continue conducting mandatory oral proceedings...

Read more about IPO notifies Supreme Court’s latest decision on ‘Extension of Limitation’; Monsanto and Nuziveedu settle long standing patent dispute and more

Changes to UK IP Law from 1st January 2021, Indian Designs added to WIPO Global Design Database, AI related patent applications double and more

In this week’s Patent News – Indian Designs added to WIPO Global Design Database; EPO invalidates Amgen’s patent claims protecting drug - Praluent, rules in...

Read more about Changes to UK IP Law from 1st January 2021, Indian Designs added to WIPO Global Design Database, AI related patent applications double and more

CPI(M) asks Government to issue compulsory license for Remdesivir, EPO creates search strategies to help fight against COVID-19 and more patent news

In this week’s Patent News – CPI(M) asks Government to issue compulsory license for manufacturing generic versions of drug – Remdesivir; EPO creates search strategies...

Read more about CPI(M) asks Government to issue compulsory license for Remdesivir, EPO creates search strategies to help fight against COVID-19 and more patent news